Portia Smallbone, MBBS (Hons)
Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2016 | University of Western Australia, Perth, AU, Bachelor of Medicine and Surgery (MBBS) |
Postgraduate Training
| 2023-2024 | Clinical Fellow, Bone Marrow Transplantation and Stem Cell Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2020-2023 | Postgraduate Fellow, Laboratory Haematology, Fiona Stanley Hospital, Sir Charles Gairdner Hospital, Royal Perth Hospital, Perth |
| 2020-2023 | Clinical Fellow, Clinical Haematology, Fiona Stanley Hospital, Sir Charles Gairdner Hospital, Royal Perth Hospital, Perth |
| 2016-2020 | Resident, Internal Medicine, Sir Charles Gairdner Hospital, Perth |
Board Certifications
| null | ECFMG Step 1-3, OET |
Experience & Service
Institutional Committee Activities
Member, Donor Selection Commitee, 2024 - Present
National Trainee Representative, Committee for Joint College Training in Haematology, 2022 - 2023
Education Officer, Western Australian College Trainees Committee, 2020 - 2022
Member, Western Australian College Trainees Committee, 2020 - 2022
Honors & Awards
| 2024 | ASTCT Clinical Research Training Course Scholar, American Society for Transplantation and Cellular Therapy (ASTCT) |
| 2024 | EHA Travel Grant, European Hematology Association (EHA) |
| 2024 | RESILIENT After cGVHD Travel Grant, American Society for Transplantation and Cellular Therapy (ASTCT) |
| 2014 | Sobotka Scholarship Recipient, The University of Western Australia |
| 2013 | Coral Haughie Memorial Prize, The University of Western Australia |
| 2013 | Medical Graduates Association Prize, The University of Western Australia |
| 2011 | John Flynn Scholarship, The University of Western Australia |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Marcoux CM, Alousi AM, Im J, Hill LC, Smallbone P, Popat U, Hosing C, Kebriaei P, Olson A, Mehta R, Chen G, Qazilbash M, Shpall E, Champlin RC, Saliba RM. Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease. Bone Marrow Transplant 59(11):1594-1600, 2024. e-Pub 2024. PMID: 39187601.
- Lambert N, Forte F, El Moussaoui M, Monseur J, Raus N, Polushin A, Michonneau D, Shultz C, Hogan WJ, Balaguer-Rosello A, Gil-Perotin S, Brijs J, Chauvet P, Gavriilaki M, Carre M, Dulamea AO, Chalandon Y, Salmenniemi U, Duminuco A, Ram R, Garcia-Cadenas I, Porto G, Nguyen S, Smallbone P, Gonzalez-Vicent M, Santoro JD, Willems E, Baron F, Servais S, Beguin Y, Maquet P. Central nervous system manifestations in acute and chronic graft-versus-host disease. Brain, 2024. e-Pub 2024. PMID: 39442000.
- Di Ciaccio PR, Mills G, Shipton MJ, Campbell B, Gregory G, Langfield J, Greenwood M, McKeague S, Shanavas M, Eslick R, Kidson-Gerber G, Smallbone P, Tang C, Morris K, Bilmon I, Yannakou CK, Badoux X, Berkahn L, Farina S, Mason KD, Motum P, Goss K, Hamad N. The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance. Br J Haematol 201(5):887-896, 2023. e-Pub 2023. PMID: 36880558.
- Fysh ETH, Smallbone P, Mattock N, McCloskey C, Litton E, Wibrow B, Ho KM, Lee YCG. Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study. Crit Care Explor 2(1):e0070, 2020. e-Pub 2020. PMID: 32166290.
- Kuzich JA, Hutchison AP, Lim KJC, Smallbone P, Denning K, Wright MP, Cull G, Leahy MF, Joske DJL, Radeski D, Purtill D. Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of 'real-world' experience from Western Australia. Leuk Lymphoma 60(14):3417-3425, 2019. e-Pub 2019. PMID: 31304820.
Other Articles
- Smallbone P, Louw A, Purtill D Laboratory methods of monitoring disease response after allogeneic haematopoietic stem cell transplantation for myelofibrosis. Pathology 56(1):24-32, 2024. PMID: 38071159.
- Lambert N, Forte F, El Moussaoui M, Monseur J, Raus N, Polushin A, Michonneau D, Schultz C, Smallbone P, Maquet P Central nervous system manifestations in acute and chronic graft-versus-host disease. Lancet Haematology.
- Alousi A, Marcoux C, Im J, Hill L, Smallbone P, Mehta R Gastrointestinal Involvement Refines Prognosis in Minnesota Standard Risk Acute Graft-vs-Host Disease. Bone Marrow Transplantation.
- Smallbone P, Amanuel B, Robbins PD, Passage J, Grove CS EBV-associated diffuse large B cell lymphoma arising within atrial myxoma in an immunocompetent patient can be treated successfully with surgery alone. Pathology 52(3):379-382, 2020. PMID: 32107076.
Abstracts
- Fysh E, Smallbone P, Mccloskey C, Roberts B, Litton E, Ho KM, Wibrow B, Lee YCG. Pleural Research In Intensive Care (PRINCE-1) A Prospective Observational Study Of Pleural Effusion Management. Respirology 22:60-61, 2017. e-Pub 2017.
Letters to the Editor
- Smallbone, PI, Sekhar, M, Srour, S, Ramdial, JL, Carmicheal Kusy, CL, Shpall, E, Popat, UR. Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis and Splanchnic Vein Thrombosis. Am J Hematol 100: 305-309, 2025.
Selected Presentations & Talks
International Presentations
- 2024. T Cell Depletion vs Post Transplant Cyclophosphamide. Invited. International Society of Cell Therapy Conference. Vancouver, CA.
- 2023. Minimal Residual Disease Assessment in Myelofibrosis. Conference. State Haematology Society of Australia & New Zealand (HSANZ) Meeting, AU.
- 2022. Haemorrhagic cystitis: a single centre study. Conference. Western Australian State Transplant Meeting, AU.
- 2021. Chromosome 1 abnormalities in multiple myeloma. Conference. Royal Australasian College of Physicians (RACP) State Conference. Melbourne, AU.
- 2017. Pleural Research in Intensive Care: A Prospective Observational Study of Pleural Effusion Management (PRINCE-1. Conference. Asia Pacific Society of Respirology (APSR).
Grant & Contract Support
| Date: | 2025 - 2027 |
| Title: | Topical ruxolitinib for the treatment of chronic genital GVHD |
| Funding Source: | NIH/NCI |
| Role: | PI |
Patient Reviews
CV information above last modified April 02, 2025